SCHEMBL9052709

SCHEMBL9052709

Cn1cc2cc3ncc(-c4ccc(Cl)s4)nc3cc2n1.Cn1ncc2cc3ncc(-c4ccc(Cl)s4)nc3cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 2/20 0.38
KIT P10721 1/20 0.38
FLT3 P36888 1/20 0.38
FGFR3 P22607 4/20 0.36
KDR P35968 3/20 0.36
PDGFRA P16234 1/20 0.35
FGFR1 P11362 3/20 0.35
FGFR2 P21802 3/20 0.35
FGFR4 P22455 3/20 0.35
GRIN2B Q13224 8/20 0.33
GRIN1 Q05586 3/20 0.33
ALDH1A1 P00352 2/20 0.32
HSD17B10 Q99714 2/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
TSHR P16473 1/20 0.32
TRPM5 Q9NZQ8 1/20 0.32
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6619205 0.90 PDGFRB (0.41) PDGFRBKITFLT3FGFR3KDR
SCHEMBL6615006 0.90 PDGFRB (0.41) PDGFRBKITFLT3FGFR3KDR
SCHEMBL9053687 0.73 PDGFRB (0.43) PDGFRBKITFLT3FGFR3KDR
SCHEMBL8103024 0.68 FGFR3 (0.37) PDGFRBKITFLT3FGFR3KDR
SCHEMBL8887646 0.68 NPC1 (0.56) PDGFRBKITFLT3KDRPDGFRA
SCHEMBL8499837 0.67 PDGFRB (0.53) PDGFRBPDGFRAGRIN2BGRIN1ALDH1A1
SCHEMBL6616898 0.67 PDGFRB (0.40) PDGFRBKITFLT3FGFR3KDR
SCHEMBL6618710 0.67 PDGFRB (0.40) PDGFRBKITFLT3FGFR3KDR
SCHEMBL8500901 0.67 PDGFRB (0.71) PDGFRBPDGFRAALDH1A1MAPTKDM4E
Hydrochloric Acid SCHEMBL8563702 0.66 PDGFRB (0.52) PDGFRBPDGFRAGRIN2BGRIN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996007658-A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-03-14 WO disclosed
US-5476851-A Administering as therapeutic agents for various disease states which are characterized by uncontrolled cellular proliferation RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1995-12-19 US disclosed